You searched for united kingdom - Page 48 of 55

News and Trends 2 Jul 2020

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

…closing of the Series C round, Freeline also stated that “it expects to consider additional capital raising options this year, which could include an initial public offering in the United…

July 2, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of…

October 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 10 Nov 2022

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

…total of approximately 320 patients with a maximum of 50 to 57 per indication in Europe and the United States. SOTIO entered into a clinical trial collaboration and supply agreement…

November 10, 2022 - 4 minutesmins - By Liza Laws

News and Trends 20 Apr 2017

Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn

…not go for the renewal of its marketing authorization for Glybera in Europe, which is set to expire in October this year. Since Glybera missed approval in the United States,…

April 20, 2017 - 3 minutesmins - By Evelyn Warner

More News! 7 Nov 2022

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

…congenital hearing loss, around 20,000 people are affected in the United States and in Europe. Sensorion has progressed preclinical and clinical development plans for OTOF-GT and is on track to…

November 7, 2022 - 2 minutesmins - By Liza Laws

In Depth 12 Jul 2017

Genomic Testing in Oncology: From Single Genes to Whole Genomes

…for Molecular Pathology v. Myriad Genetics“ challenged the validity of gene patents in the United States, specifically patents owned by Myriad Genetics that covered human DNA sequences, including BRCA. Since…

July 12, 2017 - 5 minutesmins - By Timothé Cynober

Merck, drug development, lab work, lab worker, scientist

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

…free guidebook to navigate through the important considerations necessary to successfully bring a molecule to the clinic. *The Life Science business of Merck operates as MilliporeSigma in the United States…

January 26, 2022 - 8 minutesmins - By Sudha Sundaram

News and Trends 17 Aug 2022

AUM LifeTech secures $400,000 grant for lung cancer immunotherapy program

…United States continues to be at the forefront of biomedical innovation, technology, and business due to immigrant founders and leaders like Veenu, who leave no stone unturned and persevere even…

August 17, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 30 Nov 2017

Interview: Why Asian CROs are Turning to the European Biotech Market

…of their customer base in the United States. As their coverage of the US has become more comprehensive, they are now looking for markets that are less well covered. A…

November 30, 2017 - 11 minutesmins - By External Contributor

Interview 11 Dec 2017

Edwin Moses on how Ablynx has made it to the top of European biotech

…and supportive investors in the US. But what we probably miss a little bit is the talent that exists in the United States, where they’ve had so many years of…

December 11, 2017 - 8 minutesmins - By Clara Rodríguez Fernández

Expert Advice 7 Aug 2019

Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience

…and focused on rare diseases. There are 7,000 rare diseases that affect 60 million people in Europe and the United States, but only 5% have treatments today. These often affect…

August 7, 2019 - 13 minutesmins - By Helen Albert

Best in Biotech 26 Nov 2024

Seven miRNA-focused companies pioneering new therapies in 2024

…grant for the development of CTX-002 for the treatment of progressive inflammatory lung disorders. In October 2023, the same program was awarded $3.8 million from the United States Department of…

November 26, 2024 - 9 minutesmins - By Jules Adam

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: united kingdom

Freeline Closes €106M Series C to Progress Hemophilia Gene Therapy

FDA fast tracks Immutep non-small cell lung cancer candidate

SOTIO reveal potential treatment for adults with solid tumors at SITC meeting

Goodbye Glybera! The World’s First Gene Therapy will be Withdrawn

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Genomic Testing in Oncology: From Single Genes to Whole Genomes

Top Reasons to Outsource Your Early Clinical Pipeline to a CDMO

AUM LifeTech secures $400,000 grant for lung cancer immunotherapy program

Interview: Why Asian CROs are Turning to the European Biotech Market

Edwin Moses on how Ablynx has made it to the top of European biotech

Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience

Seven miRNA-focused companies pioneering new therapies in 2024

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!